AI Searches an Early Sign of Osteoarthritis from an X-Ray Image

Researchers from the University of Jyväskylä and the Central Finland Health Care District have developed an AI based neural network to detect an early knee osteoarthritis from x-ray images. AI was able to match a doctors’ diagnosis in 87% of cases. The result is important because x-rays are the primary diagnostic method for early knee osteoarthritis.

Read more ...

AI Model Proactively Predicts if a COVID-19 Test might be Positive or Not

COVID-19 and its latest Omicron strains continue to cause infections globally. Serology (blood) and molecular tests are the two most commonly used methods for rapid COVID-19 testing. Because COVID-19 tests use different mechanisms, they vary significantly. Molecular tests measure the presence of viral SARS-CoV-2 RNA while serology tests detect the presence of antibodies triggered by the SARS-CoV-2 virus.

Read more ...

Creating a Vehicle for the NHS Frontline to Scale Real Solutions

Opinion Article by Professor Ann-Marie Cannaby, senior NHS nurse and member of the BT Clinical Advisory Board, BT Enterprise.
I have spent my career in nursing. From my earliest days working on wards to now being a Chief Nurse, it has remained very clear to me that people at the frontline of service delivery often best understand the problems and challenges facing healthcare.

Read more ...

Siemens Healthineers Opens New Ultrasound Manufacturing Facility in Košice, Slovakia

Siemens Healthineers opened a new Ultrasound manufacturing facility in Košice, Slovakia, its first in Europe, with an initial capacity of up to 120 systems per week. The company will use this new facility to expand manufacturing capabilities for its ultrasound products, including the Acuson Sequoia and the Acuson Redwood.

Read more ...

Finding the Right AI for You

The human genome is three billion letters of code, and each person has millions of variations. While no human can realistically sift through all that code, computers can. Artificial intelligence (AI) programs can find patterns in the genome related to disease much faster than humans can. They also spot things that humans miss.

Read more ...

Great Ormond Street Hospital to Equip Radiologists with Modern Medical Imaging Technology from Sectra

Healthcare professionals at one of the world's leading children's hospitals will benefit from digital imaging tools that will enhance how they assess x-rays, CTs, MRIs and other scans that are crucial for effective diagnoses.

Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) will deploy an enterprise imaging solution, including a picture archiving and communication system (PACS), from medical imaging technology provider Sectra.

Read more ...

Heart Attack on a Chip

Researchers at the University of Southern California Alfred E. Mann Department of Biomedical Engineering have developed a "heart attack on a chip," a device that could one day serve as a testbed to develop new heart drugs and even personalized medicines.

Read more ...

Black Country Pathology Services Delivers 'Biggest Go-Live to Date' with Clinisys

Black Country Pathology Services has seen its "biggest go-live to date" with the Clinisys laboratory information system that is being rolled-out to all of its laboratories.

The Dudley lab had a successful “big bang” go-live with WinPath Enterprise at the end of September and went-live with the Clinisys Integrated Clinical Environment, or ICE, at the same time.

Read more ...

Fitbit, Apple Watch Screening for Faulty Heart Rhythms Needs More Study

Company claims are leaping ahead of medical science in promoting the use of smartwatches to screen for heart rhythm disorders.

That's the conclusion of a UC San Francisco cardiologist who specializes in arrhythmias and was among the first to explore the potential of smartwatches to alert wearers about possible atrial fibrillation (AF), a serious condition that can sometimes lead to deadly strokes.

Read more ...

Bayer Advances Radiology Development Portfolio and Fosters Innovation in AI

Bayer moves ahead with the advancement of its comprehensive Radiology portfolio with progress on the development pipeline of new contrast agents as well as further partnerships in its digital business. The company announced today the presentation of new early clinical data for gadoquatrane, Bayer’s novel macrocyclic gadolinium-based compound currently in Phase II development, at the Radiological Society of North America (RSNA) Annual Meeting.

Read more ...